I-RESPOND Evaluation of IRbESartan (with or without HCTZ) in imProving insulin sensitivity in hypertensive patients with metabOlic syNDrome Logo (EUIPO, 11/15/2006)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark I-RESPOND Evaluation of IRbESartan (with or without HCTZ) in imProving insulin sensitivity in hypertensive patients with metabOlic syNDrome was filed as Figurative mark on 11/15/2006 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/19/2007.
The current status of the mark is "Registration expired".
#One line or one band #Curved lines or bands (except A 26.11.13) #Red, pink, orange
| Trademark form | Figurative mark |
| File reference | 005501416 |
| Application date | November 15, 2006 |
| Publication date | May 14, 2007 |
| Entry date | September 19, 2007 |
| Expiration date | November 15, 2016 |
Trademark owner
75017 Paris
FR
Trademark representatives
goods and services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| September 15, 2017 | Extension, Trade mark expired | ||
| March 10, 2017 | Transfer / Change of address, Published | ||
| October 18, 2012 | Transfer / Change of address, Published | ||
| March 7, 2012 | Change Representative, Published | ||
| February 23, 2012 | Transfer / Change of address, Published | ||
| January 30, 2012 | Transfer / Change of address, Published | ||
| May 23, 2011 | Transfer / Change of address, Published | ||
| December 1, 2009 | Change Representative, Registered |
ID: 11005501416